Cargando…

How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis

OBJECTIVES: This study was designed to analyze biomarker-related publications and patent trends which biobanks could consider in planning biosample collections for biomarker research. METHODS: Publications and patents containing the term “biomarker” in the title published between 1998 to 2017 were r...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Jae-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037391/
https://www.ncbi.nlm.nih.gov/pubmed/30023154
http://dx.doi.org/10.24171/j.phrp.2018.9.3.04
_version_ 1783338322752438272
author Lee, Jae-Eun
author_facet Lee, Jae-Eun
author_sort Lee, Jae-Eun
collection PubMed
description OBJECTIVES: This study was designed to analyze biomarker-related publications and patent trends which biobanks could consider in planning biosample collections for biomarker research. METHODS: Publications and patents containing the term “biomarker” in the title published between 1998 to 2017 were retrieved using Scopus database and Google Patents search engine. RESULTS: Over the last 20 years there has been a steady increase in biomarker-related publications and patents; however this has slowed for patents over the last few years. Publications in 2017 that contained blood, serum, and plasma search terms in the abstract accounted for 50%, and serum as a search term in the title and abstract was more numerous than those containing blood, plasma, tissue, or urine. Blood-related patents were the most common patent in the last 10 years, and accounted for 110 patents in 2017. Biomarker-related publications since 2010 containing RNA and protein search terms in the title and abstract, were more numerous than those containing DNA and metabolite search terms. More than 27% of biomarker-related publications in 2017 and 21% of biomarker-related patents were associated with cancer. CONCLUSION: The results of this study will help biobanks establish a biosample collection strategy for clinical application.
format Online
Article
Text
id pubmed-6037391
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Korea Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-60373912018-07-18 How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis Lee, Jae-Eun Osong Public Health Res Perspect Original Article OBJECTIVES: This study was designed to analyze biomarker-related publications and patent trends which biobanks could consider in planning biosample collections for biomarker research. METHODS: Publications and patents containing the term “biomarker” in the title published between 1998 to 2017 were retrieved using Scopus database and Google Patents search engine. RESULTS: Over the last 20 years there has been a steady increase in biomarker-related publications and patents; however this has slowed for patents over the last few years. Publications in 2017 that contained blood, serum, and plasma search terms in the abstract accounted for 50%, and serum as a search term in the title and abstract was more numerous than those containing blood, plasma, tissue, or urine. Blood-related patents were the most common patent in the last 10 years, and accounted for 110 patents in 2017. Biomarker-related publications since 2010 containing RNA and protein search terms in the title and abstract, were more numerous than those containing DNA and metabolite search terms. More than 27% of biomarker-related publications in 2017 and 21% of biomarker-related patents were associated with cancer. CONCLUSION: The results of this study will help biobanks establish a biosample collection strategy for clinical application. Korea Centers for Disease Control and Prevention 2018-06 /pmc/articles/PMC6037391/ /pubmed/30023154 http://dx.doi.org/10.24171/j.phrp.2018.9.3.04 Text en Copyright ©2018, Korea Centers for Disease Control and Prevention http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Article
Lee, Jae-Eun
How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title_full How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title_fullStr How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title_full_unstemmed How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title_short How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis
title_sort how should biobanks collect biosamples for clinical application? a 20-year biomarker-related publication and patent trend analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037391/
https://www.ncbi.nlm.nih.gov/pubmed/30023154
http://dx.doi.org/10.24171/j.phrp.2018.9.3.04
work_keys_str_mv AT leejaeeun howshouldbiobankscollectbiosamplesforclinicalapplicationa20yearbiomarkerrelatedpublicationandpatenttrendanalysis